Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.
about
Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral TreatmentOrigin of the human malaria parasite Plasmodium falciparum in gorillasResistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical ImplicationsIdentifying Recent HIV Infections: From Serological Assays to GenomicsUsing nonhuman primates to model HIV transmissionAre human endogenous retroviruses pathogenic? An approach to testing the hypothesisHomologous recombination in negative sense RNA virusesNew tools for quantifying HIV-1 reservoirs: plasma RNA single copy assays and beyondMolecular ecology and natural history of simian foamy virus infection in wild-living chimpanzeesSimple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutationsLikely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistanceLow-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral useThe evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approachPrevalence and impact of minority variant drug resistance mutations in primary HIV-1 infectionDevelopment of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutationsElucidation of hepatitis C virus transmission and early diversification by single genome sequencingLow-cost ultra-wide genotyping using Roche/454 pyrosequencing for surveillance of HIV drug resistanceBase-calling algorithm with vocabulary (BCV) method for analyzing population sequencing chromatogramsHistone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failureHIV-1 pol diversity among female bar and hotel workers in Northern TanzaniaDeep sequencing of protease inhibitor resistant HIV patient isolates reveals patterns of correlated mutations in Gag and proteaseA New Method for Rapid Screening of End-Point PCR Products: Application to Single Genome Amplified HIV and SIV Envelope AmpliconsExtremely High Mutation Rate of HIV-1 In VivoRapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader AssayHIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, ChinaComparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical TransmissionDifferences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder VirusSimplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide LigationMultiple sources of contamination in samples from patients reported to have XMRV infectionCross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapyIdentification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionPhylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants.Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplificationHIV pathogenesis: dynamics and genetics of viral populations and infected cells.Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection.PAPNC, a novel method to calculate nucleotide diversity from large scale next generation sequencing data.Improved detection of artifactual viral minority variants in high-throughput sequencing data.The combination of phylogenetic analysis with epidemiological and serological data to track HIV-1 transmission in a sexual transmission case.Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine.
P2860
Q22242229-6D4F0AE5-6043-48AD-97EE-4F6DD9DB2EAAQ24631176-4EF9A7F8-0D8F-4818-8439-0E91D4DC8B69Q26777408-2E4F8535-662C-4095-9076-E3D24655CE58Q26778001-D56B8641-B392-4B82-B0F7-9D501DE81E07Q26861425-62B14D3D-425F-442A-BFDA-03E6B95859E6Q27011469-CA62D8FB-22CC-48AD-9A97-4C0B079F0731Q27024104-6ACB504E-AA76-4252-8BAB-41C5325FED35Q27027164-F23B47DA-8769-4669-BE47-14E2AF6BC9EAQ28286256-9A5D6DB9-2ECB-48E5-82D7-D0DED2CDBEF7Q28469253-2ADF6760-424C-44B0-9E56-CCB2F5421742Q28475150-E85C61B5-6D68-46B1-8479-DE83D157BACAQ28475651-00129CDD-6D63-49AD-926C-1F60279F3B9BQ28476558-92AC8A4B-A5DC-4413-A527-50442F4CB529Q28478459-0DF3E0B7-94C4-475A-BB47-F78ED05D7FCCQ28481393-04EAEC29-8136-42AE-8079-B43EF59219E1Q28482493-EC7FA16E-2621-44E8-9626-476CE0996C54Q28483383-D0524C66-9F0C-48BA-BAED-457F36A1F85DQ28485329-CFAB3362-3F9A-4D9B-B097-559CB7C59CDEQ28537694-35F7F9DA-3085-4155-B68E-AEAA270881E8Q28539186-66FF14B9-FF0D-4CAA-B881-3294A782ADCCQ28540536-96D14A45-E12E-4D8C-BF95-902FBAC02728Q28546549-4EC9B960-0384-4161-83BA-991355BFC5A6Q28548014-C9C4C6B0-6F38-4C2C-ACE8-CD535EA213BCQ28548089-0B1976AB-E03D-4ECB-AE26-A8BC88CAF1FEQ28548426-6EE9008B-84A5-493D-B815-2C8BE64B0CE3Q28550283-B41A4D6A-755D-4C51-B47C-5C92BD730308Q28550310-27104536-6885-48E1-BE9B-BD3A4A013644Q28551914-335988D7-E2C9-4B6A-A92E-878CEA491503Q28552499-B11315E0-47A7-4DF6-8453-48BF7CC46A3BQ28731925-7ADCC7A2-4D1F-4CE4-B0C4-0BACB969AE92Q28740329-1414E7F7-FE95-4921-B886-BCCD20A97597Q29619510-3FF81D08-81EA-400A-B147-B6CFC2D61E4DQ30404569-CCD0D059-6B55-425C-8BB8-0C211A9FE3DCQ30421085-5AADBAC0-AE16-4652-B4A4-23D860328AACQ30425443-599FBD76-68FE-4913-A25C-0B3317648ABBQ30469621-04E3497E-B6FE-4B78-B131-47FC98357A1DQ30788601-19381868-A844-4A97-8D39-2DEDA551428DQ30888620-BB52C0B6-F5DF-45C2-B176-10C136DA7320Q30915825-6BCCFB66-3357-4359-AAA0-7AA66FAA6F27Q32183405-C4E68A5F-7803-446E-A5AE-EE0DFBCB5627
P2860
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Multiple, linked human immunod ...... by standard genotype analysis.
@ast
Multiple, linked human immunod ...... by standard genotype analysis.
@en
type
label
Multiple, linked human immunod ...... by standard genotype analysis.
@ast
Multiple, linked human immunod ...... by standard genotype analysis.
@en
prefLabel
Multiple, linked human immunod ...... by standard genotype analysis.
@ast
Multiple, linked human immunod ...... by standard genotype analysis.
@en
P2093
P2860
P1476
Multiple, linked human immunod ...... by standard genotype analysis.
@en
P2093
Christian J Bixby
Diane Rock
Elias K Halvas
Frank Maldarelli
Holly Bazmi
John M Coffin
John W Mellors
Judith Falloon
Julia A Metcalf
Richard T Davey
P2860
P304
P356
10.1128/JCM.43.1.406-413.2005
P407
P577
2005-01-01T00:00:00Z